Telig: Betamethasone Lotion Recall - Stability Failure Risk
Teligent Pharma recalls Betamethasone Dipropionate Lotion 0.05% (Augmented) 30mL bottles due to failed stability testing. Product may not meet API particle specifications.
Lower-risk recall
Failed Stability Specifications: lot did not meet specification for the Active Pharmaceutical Ingredient (API) particle test, which was determined through routine stability testing
Contact the company
What happened, in plain English
Teligent Pharma is recalling Betamethasone Dipropionate Lotion 0.05% (Augmented) 30mL bottles because routine stability testing showed the active ingredient didn't meet particle specifications. This could mean the medication isn't stable or effective as intended. Read more at govinfonow.com/recall/35887-telig-betamethasone-lotion-recall-stability-failure-risk.
Source Summary by GovInfoNow · govinfonow.com/recall/35887-telig-betamethasone-lotion-recall-stability-failure-risk · Updated August 18, 2026 · FDA enforcement record: FDA #D-0297-2022
Cite this page
“Telig: Betamethasone Lotion Recall - Stability Failure Risk.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/35887-telig-betamethasone-lotion-recall-stability-failure-risk. Based on FDA recall #D-0297-2022 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0297-2022%22&limit=1).
Why it’s dangerous
The lotion failed stability testing for the active pharmaceutical ingredient particle count. This means the medication might not be stable or effective over time, potentially reducing its therapeutic benefit.
Who’s affected
Prescription users of this specific lotion bottle. Patients with skin conditions requiring this medication are most at risk.
How to tell if you have this one
Check for the 30mL bottle labeled 'Betamethasone Dipropionate Lotion USP, 0.05% (Augmented)' with NDC 52565-023-29 and lot number 16569 (expiring 9/2022).
- Brand
Teligent Pharma- Category
Drug
What to do — step by step
Check Product Details
Verify the product label includes NDC 52565-023-29 and lot number 16569.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Distributed Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 3 years after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Other Teligent Pharma recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0297-2022 (August 23, 2021) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0297-2022 to see it in context.
- Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.